見過ごされた決定因子と不平等な結果:生物学的モデルを超えた代謝機能障害に関連する脂肪性肝疾患の再考
Paula Iruzubieta1, Tomás de Vega2, Javier Crespo1
1Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Santander, Spain; Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain.
The lancet. Gastroenterology & hepatology
|August 30, 2025
まとめ
代謝機能障害に関連した脂肪性肝疾患 (MASLD) は,世界的に30%に及ぶが,社会的決定因子と汚名によって悪化する. これらの要因に対処することは,MASLDの有効な管理と患者の成果の改善に不可欠です.
科学分野:
- ヘパトロジー
- 公衆衛生
- 社会医学
背景:
- 代謝機能障害に関連した脂肪性肝疾患 (MASLD) は,人口の30%に影響を与える世界的な健康問題です.
- MASLDの進行は,代謝的要因,社会的および商業的な健康決定因子,および汚名によって影響されます.
- これらの決定要因は,健康上の不平等を悪化させ,MASLD患者の質の高い臨床ケアへのアクセスを妨げています.
研究 の 目的:
- MASLDの発展と進歩に社会的および商業的な決定因子の影響を調査する.
- MASLDの診断と患者の生活の質における障壁としての汚名を調査する.
- MASLDの持続可能な管理のための包括的な多部門アプローチを提案する.
主な方法:
- このパーソナルビューは,MASLDの現在の理解をまとめています.
- 社会的,商業的,医療制度の要因を統合しています.
- 証拠に基づいた包括的な管理戦略を提案しています.
主要な成果:
- 社会的および商業的な決定要因は,MASLDに有利な環境を大きく形作る.
- 診断が遅れたり 生活の質が低下したりする 軽視された障害です
- MASLDの持続可能な管理には,統合的な多部門アプローチが必要である.
結論:
- MASLDは,代謝因子以外の社会的および商業的な健康決定因子に対処する必要があります.
- 患者さんの治療結果を改善し 診断の遅延を減らすには 汚名を軽減することが不可欠です
- MASLDの効果的かつ持続可能な管理のための包括的な多部門戦略が提案されています.
関連する概念動画
01:24Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
79
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
79
01:30Liver Physiology
1.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.1K
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54